Fang Yan | Chronic Diseases | Editorial Board Member

Published on by Health Scientists

Assist. Prof. Dr. Fang Yan | Chronic Diseases | Editorial Board Member

Assistant Professor | Central South University | China

Dr. Fang Yan is an accomplished nursing scientist whose scholarship bridges gerontological care, HIV-related psychosocial health, and gender-focused public health, reflecting a rare integration of clinical insight, social inquiry, and intervention development. With academic training spanning a Bachelor’s, Master’s, Medical Doctoral degree from Xiangya Nursing School at Central South University, and a PhD from Flinders University, she has cultivated a deeply interdisciplinary approach that elevates the rigor and relevance of nursing research. Her work is grounded in both community and clinical realities, ranging from urinary incontinence management among older adults to the complex psychosocial vulnerabilities experienced by the spouses of men who have sex with men (MSM)—groups historically underrepresented in evidence-informed care frameworks. As an Assistant Professor at Xiangya Nursing School, Dr. Yan has advanced a portfolio that demonstrates methodological strength, including randomized controlled trials, systematic integrative reviews, qualitative inquiry, scale development, and mixed-method modeling. This diversity reflects not only technical competence but an ability to generate culturally informed, contextually attuned recommendations that translate research into practice. Her nurse-led hybrid self-management model for community-dwelling older adults with urinary incontinence exemplifies translational innovation, offering a scalable intervention capable of significantly improving autonomy, symptom control, and quality of life among aging populations—a demographic urgency in many regions. Equally impactful is her extensive research on the wives of MSM in China, where she examined intimate partner violence, coping mechanisms, depression, suicidal behavior, and HIV-related vulnerabilities, producing some of the earliest nursing-led insights into this hidden population. Her publications in leading journals such as the International Journal of Nursing Studies, Journal of Advanced Nursing, and Journal of Interpersonal Violence have positioned her as a rising scholar whose work contributes meaningfully to global nursing discourse. Dr. Yan’s research excellence has been recognized through numerous competitive awards—including the Vice-Chancellor’s Award for Doctoral Thesis Excellence, China Scholarship Council support, and multiple institutional accolades—affirming both scientific merit and societal relevance. Her professional service, including roles within the Hunan Nursing Association and Chinese Nursing Association, further demonstrates leadership and commitment to advancing nursing education, policy, and community impact. While her current trajectory is distinguished by strong research output, expanding international collaboration networks, scaling pilot interventions into multicenter clinical programs, and strengthening cross-cultural comparative research would enhance the global applicability and influence of her work. Future research for Dr. Fang Yan holds significant potential in developing technology-integrated geriatric self-management platforms, advancing precision-tailored psychosocial interventions for families affected by HIV-related stigma, and exploring population-specific aging health strategies across China, Australia, and Hong Kong SAR. By deepening her engagement in implementation science and health-policy translation, she is well-poised to drive transformative models of care that improve quality of life for vulnerable older adults and socially marginalized populations globally.

Profile: ORCID 

Publications

1. Yan, F. (2025). Effectiveness of a nurse-led hybrid self-management program for community-dwelling older people with urinary incontinence: A randomized controlled trial.

2. Yan, F. (2023). Perceptions of primary health care nurses and general practitioners in the care of older people with urinary incontinence.

3. Yan, F. (2023). Construction and application of a hybrid self-management model for community-dwelling older people with urinary incontinence.

4. Yan, F. (2023). Construction and application of a hybrid self-management model for community-dwelling older people with urinary incontinence.

5. Yan, F. (2022). Perceptions and help-seeking behaviours among community-dwelling older people with urinary incontinence: A systematic integrative review.

Dr. Dana Chase | Oncology | Best Researcher Award

Published on by Health Scientists

Dr. Dana Chase | Oncology | Best Researcher Award

Professor at University of California| United States

Dr. Dana M. Chase is a distinguished gynecologic oncologist whose career integrates clinical excellence, academic leadership, and impactful research. As an associate professor and fellowship program director, she has significantly advanced women’s cancer care through innovative research, particularly in ovarian, cervical, and uterine malignancies, with her findings widely published in leading journals and presented at major international conferences. Her academic training and subspecialty expertise provide a strong foundation for her role in bridging clinical practice with evidence-based research, while her leadership in mentoring fellows and trainees highlights her dedication to education. Dr. Chase has also been recognized with numerous awards for patient care, teaching, and research, underscoring her influence across multiple domains. Beyond academia, she contributes actively to community engagement and patient advocacy, further broadening the reach of her work. With a clear commitment to advancing gynecologic oncology and inspiring future researchers, she stands out as an exemplary candidate for recognition.

Professional Profile

Scopus Profile | ORCID Profile

Education

Dr. Dana M. Chase has pursued a comprehensive and rigorous educational path that laid the foundation for her distinguished career in gynecologic oncology. She began her academic journey with an undergraduate degree in Latin American Studies, followed by postbaccalaureate premedical studies that strengthened her scientific background. She then earned her medical degree, which was followed by a residency in obstetrics and gynecology, where she gained extensive clinical training and developed a strong interest in women’s health and oncology. Building upon this, she completed a highly specialized fellowship in gynecologic oncology, where she refined her expertise in managing complex gynecologic cancers and gained advanced skills in both research and clinical practice. This blend of humanities, medical training, and subspecialty fellowship has enabled her to combine a compassionate, patient-centered approach with scientific rigor. Her educational background not only shaped her clinical and research capabilities but also prepared her for leadership in academic medicine.

Experience

Dr. Dana M. Chase has built an impressive professional career that spans academic medicine, clinical practice, and research leadership in gynecologic oncology. She has served in key academic roles, including assistant, associate, and full professorships at leading medical institutions, where she has combined teaching, mentorship, and program development with advancing cancer care. As a fellowship program director, she has guided the training of future specialists, emphasizing innovation, evidence-based practice, and patient-centered care. Clinically, she has held positions as a gynecologic oncologist across major hospitals and cancer centers, where she provided advanced surgical and medical management for women with complex cancers. Her leadership extends beyond the clinic into research, with active participation in national and international collaborations, presentations at major conferences, and contributions to peer-reviewed publications. Recognized for her excellence in teaching, patient care, and research, Dr. Chase’s professional journey highlights her as a dedicated physician, educator, and influential researcher.

Research Interest

Dr. Dana M. Chase’s research interests center on advancing the understanding and treatment of gynecologic cancers, with a strong focus on ovarian, cervical, and uterine malignancies. She is particularly committed to exploring novel therapeutic approaches, including the integration of targeted therapies and innovative clinical trial designs that aim to improve patient survival and quality of life. Her work also extends to studying the role of the vaginal microbiome, inflammation, and genetic factors in cancer development and progression, highlighting her interest in precision medicine and translational research. Dr. Chase has been actively involved in collaborative projects that bridge laboratory science with clinical applications, ensuring that discoveries translate into tangible benefits for patients. Additionally, she is passionate about survivorship research, patient advocacy, and educational outreach, which complement her scientific contributions by addressing the holistic needs of women with cancer. Her research embodies a vision of innovation, collaboration, and improved patient outcomes.

Award and Honor

Dr. Dana M. Chase has received numerous awards and honors that reflect her excellence in research, teaching, clinical care, and leadership in gynecologic oncology. Early in her career, she was recognized with prestigious research and presentation awards from leading professional organizations, acknowledging her contributions to advancing the understanding and management of gynecologic cancers. She has earned accolades such as merit and travel awards from oncology foundations, humanitarian and teacher of the year honors, and recognition for outstanding research papers and clinical presentations. Her commitment to patient care has also been highlighted through physician recognition awards and consistent listings among top doctors in major medical publications. These distinctions not only demonstrate her academic and clinical achievements but also underscore her influence as a mentor, educator, and advocate. Collectively, her awards and honors signify a career dedicated to innovation, excellence, and service, establishing her as a respected leader in women’s health and oncology.

Research Skill

Dr. Dana M. Chase possesses a wide range of research skills that reflect her expertise in gynecologic oncology and her commitment to advancing scientific knowledge in women’s cancer care. She is highly skilled in designing and conducting clinical trials, particularly those exploring new therapeutic strategies, targeted treatments, and survivorship outcomes. Her ability to integrate translational research with clinical applications demonstrates proficiency in bridging laboratory findings with patient-centered interventions. She has extensive experience in data analysis, interpretation of complex clinical outcomes, and dissemination of results through peer-reviewed publications and international conference presentations. Additionally, she is adept at developing collaborative research initiatives, both nationally and internationally, fostering multidisciplinary partnerships that enhance the scope and impact of her work. Her research skills extend beyond technical expertise to include mentorship, as she effectively guides trainees and junior researchers in developing their scholarly work. Collectively, these strengths underscore her role as a capable and innovative researcher.

Publications Top Notes

Title: Navigating complexities of polymorphic microbiomes in endometrial cancer
Authors: Dana M. Chase, et al.

Title: Real-world post-2020 first-line maintenance treatment patterns in patients with advanced ovarian cancer in the US
Authors: Dana M. Chase, et al.

Title: Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxel
Authors: Dana M. Chase, et al.

Title: Treatment patterns and outcomes by mismatch repair/microsatellite instability status among patients with primary advanced or recurrent endometrial cancer in the United States
Authors: Dana M. Chase, et al.

Title: Clinical Trial Screening in Gynecologic Oncology: Defining the Need and Identifying Best Practices
Authors: Dana M. Chase, et al.

Conclusion

In conclusion, Dr. Chase is a highly deserving candidate for the Best Researcher Award, as her contributions demonstrate excellence in clinical care, education, and translational research. Her leadership in advancing gynecologic oncology, dedication to training the next generation of specialists, and consistent engagement in impactful research reflect a career committed to improving both science and society. With her proven track record of innovation and service, combined with the potential to expand into new frontiers of cancer research, she stands as a strong role model and an exemplary figure in the academic and medical community.

Foad Kazemi | Biostatistics | Best Researcher Award

Published on by Health Scientists

Dr. Foad Kazemi | Biostatistics | Best Researcher Award

Postdoctoral Fellow at Johns Hopkins University, United States

Dr. Foad Kazemi is a highly accomplished neurosurgeon and researcher with an extensive record of impactful contributions in pediatric traumatic brain injury, neurosurgical outcomes, brain tumors, and the integration of public health and socioeconomic factors into clinical research. His work stands out for developing precision risk assessment models, predictive calculators, and patient-centered quality of life tools that translate directly into improved care. With numerous publications in leading journals, he has demonstrated both productivity and scientific depth while fostering collaborations across multiple disciplines. His innovative use of geospatial analysis, hospital frailty scores, and artificial intelligence further highlights his forward-thinking approach to advancing neurosurgery. While increased senior authorship, global visibility, and mentorship could further strengthen his profile, his achievements already reflect significant clinical relevance and societal impact. Dr. Kazemi’s body of work positions him as a strong candidate for the Best Researcher Award, deserving recognition for his contributions to science and patient care.

Professional Profile

Scopus Profile

Education

Dr. Foad Kazemi’s educational background reflects a strong foundation in medicine and neurosurgery, complemented by continuous academic development through research and scholarly contributions. As a board-certified neurosurgeon, his training has combined rigorous clinical practice with an emphasis on advancing evidence-based care in complex neurological conditions. His education has been shaped not only by formal medical and surgical training but also by an active pursuit of knowledge in fields intersecting with neurosurgery, including public health, artificial intelligence, and socioeconomic determinants of health. This multidisciplinary approach has allowed him to integrate advanced statistical modeling, geospatial analysis, and precision medicine tools into his research, elevating his clinical insights to broader scientific and societal applications. His educational journey reflects both depth and versatility, fostering the expertise necessary to lead innovative research and contribute significantly to improving patient outcomes, while also building bridges between clinical medicine, technology, and population health.

Experience

Dr. Foad Kazemi’s professional experience reflects a distinguished career as a neurosurgeon and researcher with a focus on advancing patient care through innovation and evidence-based practice. As a board-certified neurosurgeon, he has gained extensive clinical expertise in managing complex neurosurgical conditions, particularly pediatric traumatic brain injury, brain tumors, and skull base surgery. Alongside his clinical practice, he has built a strong academic and research portfolio, contributing numerous publications in high-impact journals that address not only surgical outcomes but also broader public health challenges, including socioeconomic disparities and quality of life measures. His professional work demonstrates a unique integration of clinical skills with research excellence, emphasizing predictive modeling, precision risk assessment, and the use of artificial intelligence in neurosurgery. Through multidisciplinary collaborations, he has established himself as a leader in translational research, ensuring that scientific findings are directly applicable to clinical care and policy, ultimately enhancing patient outcomes and healthcare delivery.

Research Interest

Dr. Foad Kazemi’s research interests lie at the intersection of neurosurgery, public health, and translational medicine, with a strong emphasis on improving outcomes for patients with neurological disorders. His primary focus is on pediatric traumatic brain injury, where he explores risk stratification models, predictive scoring systems, and geospatial analyses to identify disparities and optimize care. He is also deeply engaged in studying brain tumors, glioblastoma, and skull base conditions, developing precision risk assessment tools, online calculators, and quality of life instruments that translate research into practical clinical applications. In addition, he is interested in the integration of artificial intelligence, machine learning, and advanced imaging techniques to enhance diagnostic accuracy and personalize treatment strategies. His work frequently incorporates socioeconomic and demographic factors, reflecting a commitment to addressing health inequities within neurosurgery. Through these diverse research pursuits, Dr. Kazemi seeks to advance patient-centered, high-value care while contributing innovative solutions to global neurosurgical challenges.

Award and Honor

Dr. Foad Kazemi has earned recognition through his extensive contributions to neurosurgery and clinical research, reflected in multiple publications in leading international journals and collaborations with prominent researchers worldwide. His board certification as a neurosurgeon itself stands as a professional honor, signifying his expertise and commitment to the highest standards of clinical care. His work on pediatric traumatic brain injury, brain tumors, and risk prediction models has positioned him as a respected voice in both clinical and academic communities. While much of his recognition has come in the form of peer-reviewed publications and acceptance into highly regarded journals, his contributions also extend to the development of innovative tools such as predictive models and patient-centered quality of life instruments, which further highlight his role as a pioneer in translational neurosurgery. These achievements represent professional honors that underscore his dedication to advancing science, improving outcomes, and setting new standards in neurosurgical research.

Research Skill

Dr. Foad Kazemi possesses a diverse and advanced set of research skills that bridge clinical neurosurgery with innovative scientific methodologies. He is highly skilled in designing and conducting clinical studies, with expertise in pediatric traumatic brain injury, brain tumors, and neurosurgical outcomes. His proficiency extends to advanced statistical analysis, predictive modeling, and Bayesian time series approaches, which he applies to develop risk assessment tools and outcome calculators that directly benefit patient care. He has strong capabilities in utilizing artificial intelligence and machine learning for medical imaging, brain tumor classification, and health data analytics, demonstrating his ability to integrate technology with clinical practice. Additionally, his research incorporates geospatial and socioeconomic analyses, reflecting a commitment to addressing health inequities. Dr. Kazemi’s ability to collaborate across multidisciplinary teams, translate complex data into clinical applications, and publish in high-impact journals underscores his strong analytical, technical, and translational research skills.

Publications Top Notes

Title: Exploring perspectives on skull base chordoma management: a modified Delphi approach to consensus
Authors: Saket Myneni, A. Karim Ahmed, Foad Kazemi, Saraswathula A., Zwagerman N. T., Su S. Y., Choby G., Wang E. W., Van Gompel J. J., Redmond K. J., McKean E. L., Snyderman C. H., Gardner P. A., Rowan N. R., Mukherjee D

Title: Timing of pharmacological venous thromboembolism prophylaxis after firearm-related penetrating brain injury
Authors: Jiaqi Liu, Tej D. Azad, Foad Kazemi, Kathleen Renee Ran, Megan Parker, Vikas Vattipally, Carlos Aguilera, Wuyang Yang, Caitlin Hicks, Elliot Haut, Christopher D. Witiw, Debraj Raj Mukherjee, James Byrne

Title: Adverse outcomes in child abuse: a 7-year analysis of patients with traumatic brain injury
Authors: Foad Kazemi, Kai Jiang, Sarah Robinson, Alan R. Cohen

Title: Pediatric traumatic brain injury: precision risk assessment models and an online calculator for enhanced patient care
Authors: Foad Kazemi, Elena Ghotbi, Julian L. Gendreau, Alan R. Cohen

Conclusion

Overall, Dr. Kazemi is a strong candidate for the Best Researcher Award given his extensive publication record, multidisciplinary research approach, and commitment to improving neurosurgical outcomes through innovative methods. His work shows clear clinical relevance, societal importance, and scientific rigor. With continued emphasis on leadership roles in authorship, broader international visibility, and sustained mentorship contributions, his profile would align even more strongly with the qualities sought in outstanding researchers. Based on his current achievements, he is well-suited for recognition through this award.

Minzhao Lin | Biomedical Engineering | Best Researcher Award

Published on by Health Scientists

Dr. Minzhao Lin | Biomedical Engineering | Best Researcher Award

Lecturer at Dezhou University, China

Minzhao Lin, a Lecturer at Dezhou College and Ph.D. candidate in Biology and Medicine at Sun Yat-sen University, stands out as a highly promising candidate for the Best Researcher Award. His research focuses on ultrasound-based drug delivery, nanomedicine, and cancer immunotherapy—fields at the cutting edge of biomedical innovation. With over 24 peer-reviewed publications, including articles in Nature Communications, Biomaterials, and Advanced Science, Lin has made significant contributions to targeted therapies and tumor microenvironment modulation. He demonstrates technical mastery in nanocarrier design, molecular biology, and in vivo cancer models, supported by active roles in national key research projects and lab management. His interdisciplinary approach and early leadership in project coordination highlight both academic excellence and practical impact. While he could benefit from increased international exposure and independent research initiatives, his achievements clearly mark him as an outstanding young scientist, making him a strong contender for this prestigious recognition.

Professional Profile

Education🎓

Minzhao Lin has pursued a well-rounded and progressive academic journey that reflects his commitment to interdisciplinary scientific excellence. He is currently completing his Ph.D. in Biology and Medicine at Sun Yat-sen University (2020–2024), where his research focuses on nanomedicine, cancer immunotherapy, and ultrasound-responsive drug delivery systems. Prior to this, he earned a Master’s degree in Plant Prevention and Biomaterials from South China Agricultural University (2017–2020), deepening his expertise in biofunctional materials and environmental interactions. His academic foundation was laid with a Bachelor’s degree in Environmental Science from the same university (2013–2017), where he graduated with a high GPA of 4.15/5 and ranked 5th out of 330 students, a testament to his early academic excellence. Lin’s multidisciplinary education across environmental science, biomaterials, and biomedical sciences equips him with a unique ability to integrate principles from different scientific domains, making him exceptionally well-prepared for advanced research and innovation in the

field.

Professional Experience📝

Minzhao Lin has developed a strong professional foundation through a blend of academic research, project management, and teaching. Currently serving as a Lecturer at Dezhou College, he is actively involved in mentoring students and contributing to the academic community. During his Ph.D. at Sun Yat-sen University (2020–2024), he played a key administrative role in managing national research projects, including the National Natural Science Foundation of China (NSFC) and the Guangzhou Municipal Key R&D Project. He coordinated proposal submissions, managed financial accounts and procurement, ensured lab safety, and facilitated internal and external collaborations. His leadership led to successful applications for two national key grants and the completion of major project deliverables. Lin’s work spans from preclinical research to translational applications, where he contributed to drug formulation, nanocarrier development, and in vivo efficacy testing. His experience demonstrates not only research expertise but also strategic oversight, teamwork, and organizational skills essential for leading scientific initiatives.

Research Interest🔎

Minzhao Lin’s research interests lie at the intersection of nanomedicine, biomedical engineering, and cancer immunotherapy, with a strong emphasis on translational applications. His primary focus is on ultrasound-based drug delivery systems and the development of smart nanocarriers that respond to biological or external stimuli for targeted therapy. He is particularly interested in using sonogenetics and ultrasound-responsive nanomaterials to enhance the precision and penetration of therapeutic agents, especially in challenging tumor environments. Lin’s work also explores reprogramming the tumor microenvironment to overcome immunosuppression and resistance, thereby improving the efficacy of cancer immunotherapy. His interdisciplinary research integrates principles from materials science, molecular biology, and immunoengineering, aiming to design novel therapeutic platforms that can be effectively translated from bench to bedside. By combining targeted delivery strategies with immune modulation, Lin aspires to create innovative solutions for complex diseases such as triple-negative breast cancer and glioma, ultimately advancing personalized and non-invasive treatment modalitie

Award and Honor🏆

Minzhao Lin has been consistently recognized for his academic excellence and research potential through multiple prestigious awards and honors. During his undergraduate studies at South China Agricultural University, he was a three-time recipient of the National Inspirational Scholarship, an honor bestowed upon the top 5% of students for outstanding academic performance and dedication. This early recognition set the tone for his continued success in higher education. As a Ph.D. candidate at Sun Yat-sen University, he was awarded the Ph.D. Scholarship in 2023, placing him among the top 15% of doctoral students in the program. These accolades highlight his unwavering commitment to scientific inquiry and innovation. In addition to academic awards, Lin has gained recognition in the scientific community through his oral presentation at ChinaNanomedicine 2023, where he presented novel findings on tumor-targeting strategies in breast cancer. His consistent achievements underscore his emerging status as a promising and impactful young researcher.

Research Skill🔬

Minzhao Lin possesses a diverse and advanced set of research skills that span molecular biology, nanomedicine, and biomedical engineering. He is proficient in a wide range of cellular and molecular biology techniques, including flow cytometry, confocal microscopy, western blotting, qPCR, and immunohistochemistry. His expertise extends to animal experimentation and in vivo modeling, where he has successfully established tumor models such as breast cancer, hepatocellular carcinoma, and lung metastasis, and performed techniques like tail vein injections, oral gavage, and in vivo imaging. Lin is highly skilled in the design and synthesis of nanocarriers, including polymeric and lipid-based systems, for targeted drug delivery. Additionally, he is experienced in instrumental techniques like HPLC, GPC, DLS, TEM, SEM, and NMR, which are essential for material characterization. His data analysis proficiency includes software such as GraphPad Prism, R, Origin, and ChemDraw. These capabilities enable him to conduct multidisciplinary, high-impact research with precision and innovation.

Conclusion💡

Minzhao Lin is a highly promising early-career researcher whose contributions to nanomedicine and cancer immunotherapy are both innovative and impactful. His diverse skill set, high-impact publications, and multidisciplinary work on ultrasound-responsive therapeutics mark him as a strong candidate for the Best Researcher Award.

Publications Top Noted✍

  • Title: Dual-mode, regenerated DNA motor for simultaneous detection of viral gene fragments and diagnosis of infectious disease
    Authors: Wei Li, Shuaijing Wang, Minzhao Lin, Xueying Chen, Jiayue Li, Wanling Cui, Rui Wang
    Year: 2025
    Citation: Biosensors and Bioelectronics, 2025-04 | DOI: 10.1016/j.bios.2025.117186

  • Title: Overcoming chemoresistance in acute myeloid leukemia via co-delivery of siGLUT1 and hydroxycamptothecin using hyaluronic acid-conjugated nanocarriers
    Authors: Min-Zhao Lin, Min Li, Hongyan Zhang, Wei-Xiong Li, Zenglin Li, Ling-Zhi Wang, Chao Chen, Xiao-Lan Li, Hong-Jie Fan, Gang-Biao Jiang
    Year: 2025
    Citation: International Journal of Biological Macromolecules, 2025-03 | DOI: 10.1016/j.ijbiomac.2025.142492

  • Title: Track-regenerated DNA motor based on magnetic separation for sensitive and sustainable detection of viral RNA and acetamiprid
    Authors: Wei Li, Shuaijing Wang, Jiayue Li, Manman Duan, Shang Sun, Guanghao Yang, Minzhao Lin
    Year: 2025
    Citation: Microchemical Journal, 2025-03 | DOI: 10.1016/j.microc.2025.113297

  • Title: RCA-Supported Multipedal DNA Walker Integrated with TSDR for Simultaneous Detection of Single Nucleotide Polymorphisms in Circulating Tumor DNA
    Authors: Wei Li, Jiayue Li, Minzhao Lin, Kai Liu, Xiaoting Liu, Yi Zhou, Rui Wang
    Year: 2025
    Citation: Analytical Chemistry, 2025-03-25 | DOI: 10.1021/acs.analchem.5c00557

  • Title: Core–Satellite Nanoassembly Overcomes Spatial Heterogeneity of Dendric Cell Distribution in Pancreatic Tumors for Effective Chemoimmunotherapy
    Authors: Gengjia Chen, Bo Li, Tan Li, Minzhao Lin, Huihai Zhong, Xiaoxue Xie, Qiaoyun Zhang, Qi Chen, Xiaochun Meng, Zecong Xiao
    Year: 2025
    Citation: ACS Nano, 2025-02-04 | DOI: 10.1021/acsnano.4c15444

  • Title: Light-inducible nanodrug-mediated photodynamic and anti-apoptotic synergy for enhanced immunotherapy in triple-negative breast cancer
    Authors: Jing Huang, Xingliang Liu, Minzhao Lin, Zecong Xiao, Xintao Shuai
    Year: 2024
    Citation: Biomaterials Science, 2024 | DOI: 10.1039/d4bm00083h

  • Title: Îł-Glutamyl transpeptidase-activable nanoprobe crosses the blood-brain barrier for immuno-sonodynamic therapy of glioma
    Authors: Bo Li, Gengjia Chen, Huihai Zhong, Tan Li, Minzhao Lin, Huiye Wei, Qiaoyun Zhang, Qi Chen, Jinsheng Huang, Xintao Shuai
    Year: 2024
    Citation: Nature Communications, 2024-11-29 | DOI: 10.1038/s41467-024-54382-z

  • Title: Ultrasound-irradiated bindable microbomb opens the blood-brain barrier to enhance glioma therapy
    Authors: Bo Li, Huihai Zhong, Huiye Wei, Gengjia Chen, Minzhao Lin, Sicong Huang, Qiaoyun Zhang, Chengfen Xing, Tan Li, Jinsheng Huang
    Year: 2024
    Citation: Nano Today, 2024-06 | DOI: 10.1016/j.nantod.2024.102312

  • Title: Metal-organic framework nanoparticles hitchhiking on T cells for protein delivery to boost anticancer immunotherapy
    Authors: Jing Huang, Zecong Xiao, Minzhao Lin, Huihai Zhong, Xintao Shuai
    Year: 2024
    Citation: Nano Today, 2024-02 | DOI: 10.1016/j.nantod.2023.102102

  • Title: Twins‐like nanodrugs synchronously transport in blood and coalesce inside tumors for sensitive ultrasound imaging and triggerable penetrative drug delivery
    Authors: Yujun Cai, Gengjia Chen, Minzhao Lin, Bo Li, Huihai Zhong, Tan Li, Zecong Xiao, Yong Wang, Xintao Shuai
    Year: 2024
    Citation: Aggregate, 2024-01-04 | DOI: 10.1002/agt2.476

  • Title: Nanodrug regulates ROS homeostasis via enhancing fatty acid oxidation and inhibiting autophagy to overcome tumor drug resistance
    Authors: HaiYang Wang, Minzhao Lin, Gengjia Chen, Zecong Xiao, Xintao Shuai
    Year: 2023
    Citation: Biomaterials Science, 2023 | DOI: 10.1039/d3bm01139a

  • Title: Anchoring Microbubbles on Cerebrovascular Endothelium as a New Strategy Enabling Low‐Energy Ultrasound‐Assisted Delivery of Varisized Agents Across Blood‐Brain Barrier
    Authors: Bo Li, Yuejun Lin, Gengjia Chen, Mingyue Cai, Huihai Zhong, Zecong Xiao, Minzhao Lin, Tan Li, Yujun Cai, Xintao Shuai
    Year: 2023
    Citation: Advanced Science, 2023-11 | DOI: 10.1002/advs.202302134